{{Infobox disease 
 | Name            = Autoimmune diseases 
 | Image           = 
 | Caption         = 
 | DiseasesDB      = 28805 
 | ICD10           = {{ICD10|D|84|9|d|84}}, {{ICD10|M|35|9|m|35}} 
 | ICD9            = {{ICD9|279.4}} 
 | ICDO            = 
 | OMIM            = 109100 
 | MedlinePlus     = 000816 
 | eMedicineSubj   = 
 | eMedicineTopic  = 
 | MeshID          = D001327 
}}

'''Autoimmune diseases''' arise from an inappropriate [[immune response]] of the body against substances and tissues normally present in the body ([[autoimmunity]]). This may be restricted to certain [[organ (anatomy)|organ]]s (e.g. in [[autoimmune thyroiditis]]) or involve a particular tissue in different places (e.g. [[Goodpasture's disease]] which may affect the [[basement membrane]] in both the [[lung]] and the [[kidney]]). The treatment of autoimmune diseases is typically with [[immunosuppression]]&mdash;medication that decreases the immune response. A large number of autoimmune diseases are recognised.

==Criteria==
For a disease to be regarded as an autoimmune disease it needs to answer to ''Witebsky's postulates'' (first formulated by [[Ernst Witebsky]] and colleagues in 1957 and modified in 1994):<ref name=EW>{{cite journal | author=Witebsky E, Rose NR, Terplan K, Paine JR, Egan RW | title=Chronic thyroiditis and autoimmunization | journal=J. Am. Med. Assoc. | year=1957 | volume=164 | issue=13 | pages=1439–47 | pmid=13448890 | doi=10.1001/jama.1957.02980130015004}}</ref><ref>{{Cite journal|author=Rose NR, Bona C |title=Defining criteria for autoimmune diseases (Witebsky's postulates revisited) |journal=Immunol. Today |volume=14 |issue=9 |pages=426–30 |year=1993 |month=September |pmid=8216719 |doi= 10.1016/0167-5699(93)90244-F}}</ref>
* Direct evidence from transfer of pathogenic antibody or pathogenic T cells
* Indirect evidence based on reproduction of the autoimmune disease in experimental animals
* Circumstantial evidence from clinical clues

==Classification==
It is possible to classify autoimmune diseases by corresponding type of [[hypersensitivity]]: [[Type II hypersensitivity|type II]], [[Type III hypersensitivity|type III]], or [[Type IV hypersensitivity|type IV]]. (No type of autoimmune disease mimics [[type I hypersensitivity]].)<ref name="isbn0-8153-4093-1">{{cite book |author=Parham, Peter |title=The immune system |publisher=Garland Science |location=NY |year=2005 |page=344 |isbn=0-8153-4093-1 |oclc= |doi= |accessdate=}}</ref>

There is continuing debate about when a disease should be considered autoimmune, leading to different criteria such as [[Witebsky's postulates]].

{{dynamic list}}

{| class="wikitable"
|-
! Name:
! Accepted/<br/>suspected
! Hypersensitivity 
I, II, III, IV
! Autoantibody
! Notes
 |- 
 |  [[Acute disseminated encephalomyelitis]] (ADEM)  || Accepted<ref name="Mesh">{{MeshName|Autoimmune+Diseases}}</ref>  ||  || || 
 |-
 |  [[Addison's disease]] || || ||interferon omega; transglutaminase; aromatic acid carboxylase; [[Glutamate decarboxylase|GAD]]; [[HAI]]{{disambiguation needed|date=January 2013}}; [[17 hydroxylase]]; [[21 hydroxylase]] ||
 |-
 |  [[Agammaglobulinemia]] || || || ||[[IGHM]]; [[IGLL1]]: [[CD79A]]; [[CD79B]]; [[BLNK]]; [[LRRC8A]]
 |-
 |  [[Alopecia areata]]  || Accepted<ref>American Academy of Dermatology, http://www.aad.org/public/publications/pamphlets/common_alopecia.html</ref><ref>HtmlThe University of Texas MD Anderson Cancer Center, http://www.mdanderson.org/patient-and-cancer-information/cancer-information/cancer-types/alopecia-areata/index.html</ref> ||  ||  T-cells ||
 |-
 |  [[Amyotrophic lateral sclerosis]] (Also [[Lou Gehrig's disease]]; [[Motor Neuron Disease]]) || || || ||[[Valosin-containing protein|VCP]], [[ATXN2]], [[OPTN]], [[FIG4]], [[TARDBP]], [[Angiogenin|ANG]], [[VAPB]], [[FUS]], [[SETX]], [[ALS2]], [[SOD1]]
 |- 
 |  [[Ankylosing Spondylitis]]  || Suspected<ref>{{cite journal |author=J Sieper, J Braun, M Rudwaleit, A Boonen, and A Zink |title= Ankylosing spondylitis: an overview |journal=Annals of the Rheumatic Diseases |volume=61 |issue=3 |pages=iii8 |year=2002 |pmc=1766729 |doi=10.1136/ard.61.suppl_3.iii8 |pmid=12381506}}</ref><ref>{{cite journal |author=Khan MA, Khan MK|title= Diagnostic Value of HLA-B27 Testing in Ankylosing Spondylitis and Reiter's Syndrome |journal=Annals of Internal Medicine |volume=96 |issue=1 |pages=70–76; author reply 76 |year=1982 |pmid=7053711 |doi=10.1136/ard.61.suppl_3.iii8}}</ref>  ||  || ||[[CD8]]; [[HLA-B27]]
 |-
 |  [[Antiphospholipid syndrome]] ||Accepted<ref name="Mesh"/> || ||[[anti-cardiolipin]];[[anti pyruvate dehydrogenase]]; [[β2 glycoprotein I]]; [[phosphatidylserine]]; [[anti apoH]]; [[Annexin A5]] ||[[HLA-DR7]], [[HLA-B8]], [[HLA-DR2]], [[HLA-DR3]] 
 |-
 |  [[Antisynthetase syndrome]] || || || ||
 |-
 |  [[Atopic allergy]] || ||I || ||
 |-
 |  [[Atopic dermatitis]] || ||I || ||
 |-
 |  Autoimmune [[aplastic anemia]] || || || ||
 |-
 |  [[Autoimmune cardiomyopathy]] || Accepted || || ||
 |-
 |  [[Autoimmune enteropathy]] ||  || || ||
 |-
 |  [[Autoimmune hemolytic anemia]] || Accepted || II || ||complement activation
 |-
 |  [[Autoimmune hepatitis]] || Accepted || cell-mediated||[[anti-mitochondrial antibodies]]; [[Anti-nuclear antibody|ANA]]; [[anti-smooth muscle antibodies]], [[LKM-1]]; soluble liver antigen ||
 |-
 |  [[Autoimmune inner ear disease]] || Accepted || ||<ref name="urlAutoimmune Inner Ear Disease">{{cite web |url=http://www.bcm.edu/oto/grand/4893.html |title=Autoimmune Inner Ear Disease, Baylor College of Medicine|year=1993}}</ref>  ||  
 |-
 |  [[Autoimmune lymphoproliferative syndrome]] || Accepted || || ||[[TNFRSF6]]; defective Fas-CD95 apoptosis
 |-
 |  [[Autoimmune peripheral neuropathy]] || Accepted || || ||
 |-
 |  [[Autoimmune pancreatitis]] || Accepted || || [[Anti-nuclear antibody|ANA]]; [[anti-lactoferrin antibodies]][[anti-carbonic anhydrase antibodies]]; [[rheumatoid factor]]||
 |-
 |  [[Autoimmune polyendocrine syndrome]] || Accepted || Unknown or multiple || ||[[APS-1]] see [[Addison's disease]]
 |-
 |  [[Autoimmune progesterone dermatitis]] || Accepted || || ||
 |-
 |  [[Autoimmune thrombocytopenic purpura]] || Accepted || ||anti gpIIb-IIIa or 1b-IX ||
 |-
 |  [[Autoimmune urticaria]] || Accepted ||<ref>{{cite journal |author=Soundararajan S, Kikuchi Y, Kusumam J, Kaplan AP |title=Functional  &#124;  assessment of pathogenic IgG subclass in chronic autoimmune urticaria |journal=Journal of Allergy and Clinical|volume=115 |issue=4 |pages=815–21 |year=2004 |doi=10.1016/j.jaci.2004.12.1120 |unused_data=Immunology}}</ref>  || ||
 |-
 |  [[Autoimmune uveitis]] || Accepted || ||[[HLAB-27]]? ||
 |-
 |  Balo disease/[[Balo concentric sclerosis]] || || || || 
 |-
 |  [[Behçet's disease]] || Accepted || || || immune-mediated systemic vasculitis;  linkage to HLA-B51 (HLA-B27); very different manifestations with ulcers as common symptom; also called Morbus Adamandiades-Behçet
 |-
 |  [[Berger's disease]] || || || IgA (elevated in 50% of patients), IgA (in mesangial deposits on kidney biopsy)||
 |-
 |  [[Bickerstaff's encephalitis]] || || || [[Anti-GQ1b#Anti-GQ1b|Anti-GQ1b]] 2/3 patients|| similar to [[Guillain-Barré syndrome]]
 |-
 |  [[Blau syndrome]] || || || || overlaps both [[sarcoidosis]] and [[granuloma annulare]]
 |-
 |  [[Bullous pemphigoid]] || || ||IgG autoantibodies targeting the type XVII [[collagen]] component of [[hemidesmosomes]] ||<ref name="urlAutoimmune Disorders: Immune Disorders: Merck Manual Home Edition">{{cite web |url=http://www.merckmanuals.com/home/immune_disorders/autoimmune_disorders/autoimmune_disorders.html |title=Autoimmune Disorders: Immune Disorders: Merck Manual Home Health Handbook |work= |accessdate=}}</ref> 
 |-
 |  [[Cancer]] || || || ||
 |-
 |  [[Castleman's disease]] || || || || Over expression of [[Interleukin 6|IL-6]]
 |-
 |  [[Celiac disease]] || Accepted<ref name="urlCeliac Disease">{{cite web |url=http://digestive.niddk.nih.gov/ddiseases/pubs/celiac/#1 |title=Celiac Disease |work= |accessdate=}}</ref><ref name="pmid16234635">{{cite journal |author=Meize-Grochowski R |title=Celiac disease: a multisystem autoimmune disorder |journal=Gastroenterol Nurs |volume=28 |issue=5 |pages=394–402; quiz 403–4 |year=2005 |pmid=16234635 |doi= 10.1097/00001610-200509000-00005|url=http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?issn=1042-895X&volume=28&issue=5&spage=394}}</ref><ref name="pmid16214317">{{cite journal |author=Sollid LM, Jabri B |title=Is celiac disease an autoimmune disorder? |journal=Curr. Opin. Immunol. |volume=17 |issue=6 |pages=595–600 |year=2005 |month=December |pmid=16214317 |doi=10.1016/j.coi.2005.09.015 |url=http://linkinghub.elsevier.com/retrieve/pii/S0952-7915(05)00158-5}}</ref>  || IV??  || [[Anti-tissue transglutaminase antibodies]] anti-endomysial IgA, anti-gliadin IgA ||[[HLA-DQ8]] and [[DQ2.5]]
 |- 
 |  [[Chagas disease]]  || Suspected<ref>{{cite journal |author=Hyland KV, Engman DM |title=Further thoughts on where we stand on the autoimmunity hypothesis of Chagas disease |journal=Trends Parasitol. |volume=22 |issue=3 |pages=101–2; author reply 103 |year=2006 |pmid=16446117 |doi=10.1016/j.pt.2006.01.001}}</ref>  ||  || ||
 |-
 |  [[Chronic inflammatory demyelinating polyneuropathy]] || || || [[Anti-ganglioside antibodies]]:[[anti-GM1]], [[anti-GD1a]], [[anti-GQ1b]]||similar to [[Guillain-Barré syndrome]]
 |-
 |  [[Chronic recurrent multifocal osteomyelitis]] || || || ||[[LPIN2]], [[D18S60]],similar to [[Majeed syndrome]]
 |-
 |  [[Chronic obstructive pulmonary disease]] || Suspected<ref name="PMID14514931">{{cite journal |author=Agustí A, MacNee W, Donaldson K, Cosio M. |title=Hypothesis: does COPD have an autoimmune component? |journal=Thorax |volume=58 |issue=10 |pages=832–834 |year=2003 |pmid=14514931 |doi=10.1136/thorax.58.10.832 |pmc=1746486}}</ref><ref name="pmid17450149">{{cite journal |author=Lee SH, Goswami S, Grudo A, ''et al'' |title=Antielastin autoimmunity in tobacco smoking-induced emphysema |journal=Nat. Med. |volume=13 |issue=5 |pages=567–9 |year=2007 |pmid=17450149 |doi=10.1038/nm1583}}</ref>  ||  || ||
 |-
 |  [[Churg-Strauss syndrome]] || || ||[[p-ANCA]]||
 |-
 |  [[Cicatricial pemphigoid]] || || || anti-BP-1, anti BP-2||precipitates [[Complement component 3|C3]]
 |-
 |  [[Cogan syndrome]] || || || ||
 |-
 |  [[Cold agglutinin disease]] || Accepted || II ||[[IgM]]||idiopathic or secondary to leukemia or infection
 |-
 |  [[Complement component 2 deficiency]] || || || ||
 |-
 |  [[Contact dermatitis]] || ||IV || ||
 |-
 |  [[Cranial arteritis]] || || || ||aka Temporal arteritis; involves [[giant cells]]
 |-
 |  [[CREST syndrome]] || || || [[Anti-centromere antibodies]] [[Anti-nuclear antibodies]]||
 |-
 |  [[Crohn's disease]] (one of two types of idiopathic inflammatory bowel disease "IBD")  || Accepted<ref name="Mesh"/>   ||  IV || ||Innate immunity; [[Th17]]; [[Th1 cell|Th1]]; [[ATG16L1]]; [[CARD15]];[[XBP1]];
 |-
 |  [[Cushing's Syndrome]] || || ||[[cortisol binding globulin]]?||
 |-
 |  [[Cutaneous leukocytoclastic angiitis]] || || || ||neutrophils
 |-
 |  [[Dego's disease]] || || || || [[Vasculopathy]]
 |-
 |  [[Dercum's disease]] || Suspected || || ||Lipoid tissue.<ref name="pmid17448013">{{cite journal |author=Singal A, Janiga JJ, Bossenbroek NM, Lim HW |title=Dercum's disease (adiposis dolorosa): a report of improvement with infliximab and methotrexate |journal=J Eur Acad Dermatol Venereol |volume=21 |issue=5 |page=717 |year=2007 |month=May |pmid=17448013 |doi=10.1111/j.1468-3083.2006.02021.x |url=http://www.blackwell-synergy.com/openurl?genre=article&sid=nlm:pubmed&issn=0926-9959&date=2007&volume=21&issue=5&spage=717}}</ref>
 |-
 |  [[Dermatitis herpetiformis]] || || || [[IgA]]; [[Keratinocyte transglutaminase|anti-epidermal transglutaminase antibodies]] ||
 |-
 |  [[Dermatomyositis]]  || Accepted<ref name="urlPolymyositis and Dermatomyositis: Autoimmune Disorders of Connective Tissue: Merck Manual Home Health Handbook">{{cite web |url=http://www.merckmanuals.com/home/bone_joint_and_muscle_disorders/autoimmune_disorders_of_connective_tissue/polymyositis_and_dermatomyositis.html |title=Polymyositis and Dermatomyositis: Autoimmune Disorders of Connective Tissue: Merck Manual Home Health Handbook |work= |accessdate=}}</ref>  || || [[histidine-tRNA]] anti-[[signal recognition peptide]] Anti-Mi-2 [[Anti-Jo1]].<ref>{{cite journal | last=Ghirardello | first=A | coauthors=Zampieri S, Tarricone E et al. | title=Clinical implications of autoantibody screening in patients with autoimmune myositis | journal=Autoimmunity | volume=39 | issue=3 | pages=217–221 | month=May | year=2006 | pmid=16769655 | doi=10.1080/08916930600622645 }}</ref> || B- and T-cell perivascular inflammatory infiltrate on muscle biopsy
 |- 
 |  [[Diabetes mellitus type 1]]  || Accepted<ref name = "Mesh"/>   || IV || [[Glutamic acid decarboxylase antibodies]] (GADA), [[islet cell antibodies]] (ICA), and [[insulinoma-associated autoantibodies]] (IA-2), [[anti-insulin antibodies]] || HLA-DR3, HLA-DR4 ||
 |-
 |  [[Diffuse cutaneous systemic sclerosis]] || || ||[[anti-nuclear antibodies]], [[anti-centromere]] and anti-scl70/[[anti-topoisomerase antibodies]]<ref name=JimenezDerk>{{cite journal |author=Jimenez SA, Derk CT |title=Following the molecular pathways toward an understanding of the pathogenesis of systemic sclerosis |journal=Ann. Intern. Med. |volume=140 |issue=1 |pages=37–50 |year=2004 |pmid=14706971 |doi=}}</ref>|| [[COL1A2]] and [[TGF-β1]]
 |-
 |  [[Dressler's syndrome]] || || ||myocardial neo-antigens formed as a result of the MI||
 |-
 | [[Drug-induced lupus erythematosus|Drug-induced lupus]] || || ||[[Anti-histone antibodies]] ||
 |-
 |  [[Discoid lupus erythematosus]] || ||III || ||[[Interleukin 2|IL-2]] and [[IFN-gamma]]><ref>{{cite journal |author=Toro JR, Finlay D, Dou X, Zheng SC, LeBoit PE, Connoly KM|title= Detection of Type 1 Cytokines in Discoid Lupus Erythematosus |journal=Annals of Internal Medicine |volume=136 |issue= |pages=1497–1501}}</ref>
 |-
 |  [[Eczema]] || || || ||[[LEKTI]], [[SPINK5]],<ref name="pmid11544479">{{cite journal |author=Walley AJ, Chavanas S, Moffatt MF, ''et al.'' |title=Gene polymorphism in Netherton and common atopic disease |journal=Nat. Genet. |volume=29 |issue=2 |pages=175–8 |year=2001 |pmid=11544479 |doi=10.1038/ng728}}</ref> [[filaggrin]].,<ref name=filaggrin>{{cite journal |author=Palmer CN ''et al.'' |year=2006 |title=Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis |journal=Nature Genetics |volume=38 |issue=4 |pages=441–6 |pmid=16550169 |doi=10.1038/ng1767}}</ref> [[Brain-derived neurotrophic factor]] (BDNF) and [[Substance P]].<ref name="BBC-blood chemicals">{{cite news |author= |title= 'Blood chemicals link' to eczema -- Scientists have identified two blood chemicals linked to itchy eczema, offering new treatment possibilities |url= http://news.bbc.co.uk/2/hi/health/6962450.stm |date= 26 August 2007 |publisher=BBC News |accessdate=2007-10-16}}</ref>
 |-
 |  [[Endometriosis]]  || Suspected<ref>{{cite journal |author=Gleicher N, el-Roeiy A, Confino E, Friberg J |title=Is endometriosis an autoimmune disease? |journal=Obstetrics and gynecology |volume=70 |issue=1 |pages=115–22 |year=1987 |pmid=3110710 |doi=}}</ref>  ||  || ||
 |- 
 |  [[Enthesitis]]-related arthritis<ref name="PMID20606622">{{cite journal |author=Colbert RA|title=Classification of juvenile spondyloarthritis: Enthesitis-related arthritis and beyond|journal=Nat Rev Rheumatol. |volume=6 |issue=8| pages=477–85 |doi=10.1038/nrrheum.2010.103 |year=2010 }}</ref> || || ||.||[[MMP3]]<ref>{{cite journal |author=Viswanath V, Myles A, Dayal R, Aggarwal A |title=Levels of Serum Matrix Metalloproteinase-3 Correlate with Disease Activity in the Enthesitis-related Arthritis Category of Juvenile Idiopathic Arthritis |journal= J Rheumatol }}</ref> [[TRLR2]], [[TLR4]],<ref>{{cite journal |author= Myles A, Aggarwal A |title=Expression of Toll-like receptors 2 and 4 is increased in peripheral blood and synovial fluid monocytes of patients with enthesitis-related arthritis subtype of juvenile idiopathic arthritis| journal= Rheumatology (Oxford) |volume=50 |issue=3 |pages=481–8| pmid=21097451 |doi=10.1093/rheumatology/keq362 |year=2011 |month=March}}</ref> ERAP1<ref>{{cite journal |author=Hinks A, Martin P, Flynn E, Eyre S, Packham J; Childhood Arthritis Prospective Study (CAPS); BSPAR study group, Barton A, Worthington J, Thomson W.|title=Subtype specific genetic associations for juvenile idiopathic arthritis: ERAP1 with the enthesitis related arthritis subtype and IL23R with juvenile psoriatic arthritis |journal=Arthritis Res Ther |year=2001 |volume=13 |issue=1 |page=R12 |pmid= 21281511 |doi=10.1186/ar3235 |pmc=3241356}}</ref>
 |-
 |  [[Eosinophilic fasciitis]] || Accepted || || ||
 |-
|  [[Eosinophilic gastroenteritis]] ||  || || [[IgE]] || [[Interleukin 3|IL-3]], [[Interleukin 5|IL-5]], [[GM-CSF]], [[eotaxin]]
 |-
 |  [[Epidermolysis bullosa acquisita]] || || || || [[COL7A1]]
 |-
 |  [[Erythema nodosum]] || || || ||
 |-
 |  [[Erythroblastosis]] fetalis || ||II || ABO, Rh, Kell antibodies|| mother's immune system attacks fetus
 |-
 |  [[Essential mixed cryoglobulinemia]] || || || ||
 |-
 |  [[Evan's syndrome]] || || || ||
 |-
 |  [[Fibrodysplasia ossificans progressiva]] || || || || [[ACVR1]] Lymphocytes express increased [[BMP4]]
 |-
 |  [[Fibrosing alveolitis]] (or [[Idiopathic pulmonary fibrosis]]) || || || || ''[[SFTPA1]]'', ''[[SFTPA2]]'', ''[[TERT]]'', and ''[[Telomerase RNA component|TERC]]''.<ref name="Omim">{{OMIM|178500}}</ref>
 |-
 |  [[Gastritis]] || || ||serum antiparietal and anti-IF antibodies ||
 |-
 |  [[Gastrointestinal pemphigoid]] || Accepted || || || 
 |-

 |-
 |  [[Glomerulonephritis]] || Sometimes || || [[IgA]] || see [[Buerger's disease]] for [[IgA]]; [[Membranous glomerulonephritis]] for [[IgG]]; Membranoproliferative/mesangiocapillary GN ([[Complement system|Complement]] activation); [[Goodpasture's syndrome]]; [[Wegener's granulomatosis]] 
 |- 
 |  [[Goodpasture's syndrome]]  || Accepted<ref name = "Mesh"/>   || II || [[Anti-Basement Membrane Collagen Type IV Protein]] ||
 |- 
 |  [[Graves' disease]]  || Accepted<ref name = "Mesh"/>   || II ||[[thyroid autoantibodies]] (TSHR-Ab) that activate the [[Thyroid-stimulating hormone|TSH]]-receptor (TSHR) ||
 |- 
 |  [[Guillain-Barré syndrome]] (GBS)  || Accepted<ref name = "Mesh"/>   || IV  || [[Anti-ganglioside antibodies|Anti-ganglioside]] ||
 |-
 |  [[Hashimoto's encephalopathy]] || Accepted<ref name = "Mesh"/> || IV ||[[alpha-enolase]]<ref name="Yoneda_2007_Hashimoto">{{cite journal | pmid = 17335908 | doi=10.1016/j.jneuroim.2007.01.018 | volume=185 | issue=1–2 | title=High prevalence of serum autoantibodies against the amino terminal of alpha-enolase in Hashimoto's encephalopathy | year=2007 | month=April | journal=J. Neuroimmunol. | pages=195–200 | author=Yoneda M, Fujii A, Ito A, Yokoyama H, Nakagawa H, Kuriyama M}}</ref> ||
 |- 
 |  [[Hashimoto's thyroiditis]]  || Accepted<ref name = "Mesh"/>   || IV || [[antibody|antibodies]] against [[thyroid peroxidase]] and/or [[thyroglobulin]]  ||[[HLADR5]], [[CTLA-4]]
 |-
 |  [[Henoch-Schonlein purpura]] || || ||immunoglobulin A (IgA) and [[complement component 3]] (C3) ||
 |-
 |  [[Herpes gestationis]] aka [[Gestational Pemphigoid]]|| || || IgG and [[Complement component 3|C3]] misdirected antibodies intended to protect the placenta ||
 |-
 |  [[Hidradenitis suppurativa]]  || Suspected<ref>{{cite web |url=http://clinicaltrials.gov/show/NCT00329823 |title=Clinical Trial: Etanercept in Hidradenitis Suppurativa |accessdate=2007-07-08 |work=}}</ref>  ||  || ||
 |-
 |  [[Hughes-Stovin syndrome]] ||
 |-
 |  [[Hypogammaglobulinemia]] || || || ||[[IGHM]], [[IGLL1]], [[CD79A]], [[BLNK]], [[LRRC8A]], [[CD79B]]
 |-
 |  [[Idiopathic inflammatory demyelinating diseases]] || || || || a variant of [[multiple sclerosis]]
 |-
 |  [[Idiopathic pulmonary fibrosis]] || || || ||''[[SFTPA1]]'', ''[[SFTPA2]]'', ''[[TERT]]'', and ''[[Telomerase RNA component|TERC]]''.<ref name="Omim"/>
 |- 
 |  [[Idiopathic thrombocytopenic purpura]] (See [[Autoimmune thrombocytopenic purpura]]) || Accepted<ref name = "Mesh"/>   || II || || [[glycoprotein]]s [[IIb-IIIa]] or [[Ib-IX]], [[immunoglobulin G]] 
 |-
 |  [[IgA nephropathy]] || ||III? ||[[IgA]] produced from marrow rather than [[MALT]] ||
 |-
 |  [[Inclusion body myositis]] || || || || similar to [[polymyositis]] but does not respond to steroid therapy-activated T8 cells
 |-
 |  [[Chronic inflammatory demyelinating polyneuropathy]] || || || [[anti-ganglioside antibodies]]|| similar to [[Guillain–Barré syndrome]]
 |- 
 |  [[Interstitial cystitis]]  || Suspected<ref>{{cite journal |author=Kárpáti F, Dénes L, Büttner K |title=[Interstitial cystitis=autoimmune cyatitis? Interstitial as a participating disease in lupus erythematosus] |language=German |journal=Zeitschrift für Urologie und Nephrologie |volume=68 |issue=9 |pages=633–9 |year=1975 |pmid=1227191 |doi=}}</ref>  || || ||[[Mast cells]]
 |-
 |  [[Juvenile idiopathic arthritis]] aka [[Juvenile rheumatoid arthritis]] || || || inconsistent [[Anti-nuclear antibody|ANA]] [[Rheumatoid factor]] ||
 |-
 |  [[Kawasaki's disease]] || Suspected ||  || || [[ITPKC]] [[HLA-B51]]
 |-
 |  [[Lambert-Eaton myasthenic syndrome]] || || ||  [[voltage-gated calcium channels]]; [[Q-type calcium channel]], [[synaptogagmin]], [[muscarinic acetylcholine receptor M1]] ||  [[HLA-DR3-B8]]
 |-
 |  [[Leukocytoclastic vasculitis]] || || || ||
 |-
 |  [[Lichen planus]] || || || ||
 |-
 |  [[Lichen sclerosus]] || || || ||
 |-
 |  [[Linear IgA disease]] (LAD) || || || ||
 |-
 |  [[Lupoid hepatitis]] aka [[Autoimmune hepatitis]] || || ||ANA and SMA,<ref name="pmid18528935">{{cite journal |author=Bogdanos DP, Invernizzi P, Mackay IR, Vergani D |title=Autoimmune liver serology: Current diagnostic and clinical challenges |journal=World J. Gastroenterol. |volume=14 |issue=21 |pages=3374–3387 |year=2008 |month=June |pmid=18528935 |doi= 10.3748/wjg.14.3374|url=http://www.wjgnet.com/1007-9327/14/3374.asp |pmc=2716592}}</ref>  [[LKM-1]], [[LKM-2]] or [[LKM-3]]; antibodies against [[soluble liver antigen]]<ref name="urlautoimmune hepatitis">{{cite web |url=http://www.meddean.luc.edu/Lumen/MedEd/orfpath/autoimmune%20hepatitis.htm |title=autoimmune hepatitis |work= |accessdate=}}</ref><ref name="urlMedscape & eMedicine Log In">{{cite web |url=http://www.medscape.com/viewarticle/445619_14 |title=Medscape & eMedicine Log In |work= |accessdate=}}</ref> (anti-SLA, anti-LP) no autoantibodies detected (~20%){{Citation needed|date=July 2008}} ||
 |- 
 |  [[Lupus erythematosus]]  || Accepted<ref name = "Mesh"/>   || III || [[Anti-nuclear antibody|Anti-nuclear antibodies]]<ref name="pmid10501412">{{cite journal |author=Ehrenstein MR |title=Antinuclear antibodies and lupus: causes and consequences |journal=Rheumatology (Oxford) |volume=38 |issue=8 |pages=691–3 |year=1999 |month=August |pmid=10501412 |doi=10.1093/rheumatology/38.8.691 |url=http://rheumatology.oxfordjournals.org/content/38/8/691.full}}</ref> [[anti-Ro]].<ref name="Franceschini2005">{{cite pmid|15804706}}</ref> Also, they are often present in [[Sjögren's syndrome]].<ref name="Franceschini2005a">{{cite journal |author=Franceschini F, Cavazzana I |title=Anti-Ro/SSA and La/SSB antibodies |journal=Autoimmunity |volume=38 |issue=1 |pages=55–63 |year=2005 |month=February |pmid=15804706 |doi=10.1080/08916930400022954 |url=}}</ref><ref name="Goeb2007">{{cite journal |pmc=1868868 |title=Clinical significance of autoantibodies recognizing Sjögren's syndrome A (SSA), SSB, calpastatin and alpha-fodrin in primary Sjögren's syndrome |author=V Goëb et al. |year=2007 |doi=10.1111/j.1365-2249.2007.03337.x |pmid=17286756 |volume=148 |issue=2 |journal=Clin. Exp. Immunol. |pages=281–7}}</ref>||
 |-
 |  [[Majeed syndrome]] || || || ||[[LPIN2]]
 |-
 |  [[Ménière's disease]] || ||III? || major peripheral myelin protein P0<ref name="pmid11270490">{{cite journal |author=Boulassel MR, Deggouj N, Tomasi JP, Gersdorff M. |title= Inner ear autoantibodies and their targets in patients with autoimmune inner ear diseases.&#124; journa;=Acta Otolaryngol|volume=12| issue=1| pages=28–34. |year=2001 Jan}}</ref>||
 |-
 |  [[Microscopic polyangiitis]] || || ||[[p-ANCA]] myeloperoxidase ||binds to neutrophils causing them to degranulate and damages endothelium
 |-
 |  [[Miller-Fisher syndrome]] see [[Guillain-Barre Syndrome]]|| Accepted || ||[[anti-GQ1b]]
 |- 
 |  [[Mixed connective tissue disease]]  || Accepted<ref name = "Mesh"/>   || ||[[anti-nuclear antibody]] anti-[[U1-RNP]] || [[HLA-DR4]]
 |- 
 |  [[Morphea]] || Suspected<ref name="pmid15561734">{{cite journal |author=Takehara K, Sato S |title=Localized scleroderma is an autoimmune disorder |journal=Rheumatology (Oxford, England) |volume=44 |issue=3 |pages=274–9 |year=2005 |pmid=15561734 |doi=10.1093/rheumatology/keh487}}</ref>  ||  ||
 |-
 |  [[Mucha-Habermann disease]] aka [[Pityriasis lichenoides et varioliformis acuta]]|| || || ||T-cells
 |- 
 |  [[Multiple sclerosis]]  || Suspected ||IV ||Anti-KIR4.1<ref>http://www.nejm.org/doi/full/10.1056/NEJMoa1110740"</ref>|| HLA-DR2, [[PECAM-1]]<ref name="pmid14754395">{{cite journal |author= Kalinowska A, Losy J.|title=PECAM-1, a key player in neuroinflammation |journal= Eur J Neurol |volume=13 |issue=12 |pages=1284–90274|year=2006 |pmid=17116209|doi=10.1111/j.1468-1331.2006.01640.x}}</ref> [[Anti-Myelin Basic Protein]] 
 |- 
 |  [[Myasthenia gravis]]  || Accepted<ref name = "Mesh"/>   || II || [[nicotinic acetylcholine receptor]] [[MuSK protein]]||[[HA-B8]] [[HLA-DR3]] [[HLA-DR1]]
 |-
 |  [[Myositis]]   || || || || see [[Dermatomyositis]] and [[Polymyositis]] see [[Inclusion-body-myositis]]
 |-
   |  [[Narcolepsy]]<ref name="pmid19412176">{{cite journal |author=Hallmayer J, Faraco J, Lin L, et al. |title=Narcolepsy is strongly associated with the TCR alpha locus |journal=Nat. Genet. |volume=41 |issue=6 |pages=708–11 |year=2009 |month=June |pmid=19412176 |doi= 10.1038/ng.372 |pmc=2803042}}</ref><ref name="url_eurekalert">{{cite web |url=http://www.eurekalert.org/pub_releases/2009-05/sumc-nia042809.php |title=Narcolepsy is an autoimmune disorder, Stanford researcher says |date=2009-05-03 |work=EurekAlert |publisher=American Association for the Advancement of Science |accessdate=2009-05-31| archiveurl= http://web.archive.org/web/20090510122328/http://www.eurekalert.org/pub_releases/2009-05/sumc-nia042809.php| archivedate= 10 May 2009 <!--DASHBot-->| deadurl= no}}</ref>  || Suspected<ref>{{cite journal | author=Carlander, B., Eliaou J.F., Billiard M. | title=Autoimmune hypothesis in narcolepsy | journal=Neurophysiol. Clin. | volume=23 | year=1993 | doi=10.1016/S0987-7053(05)80279-5 | pages=15–22 | pmid=8446070 | issue=1}}</ref>  ||II?  || [[hypocretin]] or [[orexin]]<ref name="mignot">{{cite journal |last=Mignot |first=E |year=2001 |title=A commentary on the neurobiology of the hypocretin/orexin system |journal=Neuropsychopharmacology |volume=25 |pmid=11682267 |issue=5 Suppl |doi= 10.1016/S0893-133X(01)00316-5 |pages=S5–13}}</ref> ||[[HLA-DQB1]]*0602<ref name="Maret">{{cite journal |last=Maret |first =S |coauthors=Tafti M |title=Genetics of narcolepsy and other major sleep disorders |journal=Swiss Medical Weekly |volume=135 |issue=45–46 |pages=662–5 |publisher=EMH Swiss Medical Publishers Ltd. |month=November |year=2005 |url=http://www.smw.ch/docs/pdf200x/2005/45/smw-11162.pdf |format=PDF |pmid=16453205 |accessdate=2008-03-07| archiveurl= http://web.archive.org/web/20080414122100/http://www.smw.ch/docs/pdf200x/2005/45/smw-11162.pdf| archivedate= 14 April 2008 <!--DASHBot-->| deadurl= no}}</ref> 
 |- 
 |  [[Neuromyelitis optica]] (also Devic's disease)  || ||II? ||[[NMO-IgG]] [[aquaporin 4]].<ref name=JExpMed2005>{{cite journal |author=Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR |title=IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel |journal=J. Exp. Med. |volume=202 |issue=4 |pages=473–477 |year=2005 |pmid=16087714 |doi=10.1084/jem.20050304|url=http://www.jem.org/cgi/content/full/202/4/473 |pmc=2212860}}</ref><ref name=Pittock>{{cite journal |author=Pittock SJ, Weinshenker BG, Lucchinetti CF, Wingerchuk DM, Corboy JR, Lennon VA |title=Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression |journal=Arch. Neurol. |volume=63 |issue=7 |pages=964–968 |year=2006 |pmid=16831965 |doi=10.1001/archneur.63.7.964|url=http://archneur.ama-assn.org/cgi/content/full/63/7/964}}</ref>||
 |- 
 |  [[Neuromyotonia]]  || Suspected<ref name="MP">{{cite journal |author=Maddison P |title=Neuromyotonia |journal=Clinical Neurophysiology |volume=117 |issue=10 |pages=2118–27 |year=2006 |pmid=16843723 |doi=10.1016/j.clinph.2006.03.008}}</ref>  || II? || [[voltage-gated potassium channel]]s.<ref name="MP"/> ||
 |-
 |  [[Occular cicatricial pemphigoid]] || ||II? ||BP-1, BP-2 || C3 deposition
 |-
 |  [[Opsoclonus myoclonus syndrome]]  || Suspected ||IV? || || Lymphocyte recruitment to CSF<ref name="pmid15136676">{{cite journal |author=Pranzatelli, M. R., Travelstead, A. L., Tate, E. D., Allison, T. J.,Moticka, E. J., Franz, D. N., Nigro, M. A., Parke, J. T., Stumpf, D. A., Verhulst, S. J. |title=B- and T-cell markers in opsoclonus-myoclonus syndrome: Immunophenotyping of CSF lymphocytes |journal=Neurology |vol=62 |pages=1526–1532
|year=2004|pmid=15136676 |volume=62 |issue=9 |doi=10.1212/WNL.62.9.1526}}</ref>
 |-
 |  [[Ord's thyroiditis]] || || ||
 |-
 |  [[Palindromic rheumatism]] || || || anti-[[cyclic citrullinated peptide]] antibodies (anti-CCP) and antikeratin antibodies (AKA)<ref name="pmid18412310">{{cite journal |author=Powell A, Davis P, Jones N, Russell AS |title=Palindromic rheumatism is a common disease: comparison of new-onset palindromic rheumatism compared to new-onset rheumatoid arthritis in a 2-year cohort of patients |journal=J. Rheumatol. |volume=35 |issue=6 |pages=992–4 |year=2008 |month=June |pmid=18412310 |doi= |url=http://www.jrheum.com/subscribers/08/06/992.html}}</ref>
 |-
 |  [[PANDAS]] (pediatric autoimmune neuropsychiatric disorders associated with streptococcus) ||Suspected ||II? || ||antibodies against streptococcal infection serve as auto-antibodies 
 |-
 |  [[Paraneoplastic cerebellar degeneration]] || ||IV?<ref>{{citation |journal=Proc Natl Acad Sci U S A |author=Darnell,R.B. |title=Onconeural antigens and the paraneoplastic neurologic disorders: at the intersection of cancer, immunity, and the brain |volume=93|issue=10 |pages=4529–4536 |year=1996 |pmid= 8643438 |pmc=39311}}</ref> II? || anti-Yo<ref>{{citation |journal=Neurology |author=Peterson,K., Rosenblum, J.K., Kotanides,H., Posner,J.B. |title=Paraneoplastic cerebellar degeneration. I. A clinical analysis of 55 anti-Yo antibody-positive patients |volume=42|issue=10 |pages=1931–1937 |year=1992 |pmid= 1407575}}</ref> (anti-cdr-2<ref>{{citation |journal=Ann Neurol |author=Albert,M.L., Austin,L.M., Darnell,R.B. |title=Detection and treatment of activated T cells in the cerebrospinal fluid of patients with paraneoplastic cerebellar degeneration |volume=47|issue=1 |pages=9–17 |year=2000 |pmid= 10632096}}</ref> in purkinje fibers) anti-Hu, anti-Tr, antiglutamate receptor ||
 |-
 |  [[Paroxysmal nocturnal hemoglobinuria]] (PNH) || Sometimes(?) || || ||complement attacks RBCs
 |-
 |  [[Parry Romberg syndrome]] || || || ANA ||
 |-
 |  [[Parsonage-Turner syndrome]] || || ||
 |-
 |  [[Pars planitis]] || || || ||
 |-
 |  [[Pemphigus vulgaris]]  || Accepted<ref name = "Mesh"/>   || II || [[Anti-Desmoglein 3]]
 |- 
 |  [[Pernicious anaemia]] || Accepted<ref name="titleMedlinePlus Medical Encyclopedia: Pernicious anemia">{{cite web |url=http://www.nlm.nih.gov/medlineplus/ency/article/000569.htm |title=MedlinePlus Medical Encyclopedia: Pernicious anemia |accessdate=2008-04-05 |work=| archiveurl= http://web.archive.org/web/20080509193114/http://www.nlm.nih.gov/medlineplus/ency/article/000569.htm| archivedate= 9 May 2008 <!--DASHBot-->| deadurl= no}}</ref>   ||  II || anti-parietal cell antibody ||
 |-
 |  [[Perivenous encephalomyelitis]] || || || ||
 |-
 |  [[POEMS syndrome]] || || || ||[[IL1B|interleukin 1β]], [[interleukin 6]] and [[TNFα]]. [[vascular endothelial growth factor]] (VEGF), given the .<ref name=Dispenzieri>{{cite journal |author=Dispenzieri A, Kyle RA, Lacy MQ, ''et al.'' |title=POEMS syndrome: definitions and long-term outcome |journal=Blood |volume=101 |issue=7 |pages=2496–506 |year=2003 |pmid=12456500 |doi=10.1182/blood-2002-07-2299 | url=http://bloodjournal.hematologylibrary.org/cgi/content/full/101/7/2496}}</ref>
 |-
 |  [[Polyarteritis nodosa]] || || || ||
 |-
 |  [[Polymyalgia rheumatica]] || || || || 
 |-
 |  [[Polymyositis]]  || Accepted<ref name="urlPolymyositis and Dermatomyositis: Autoimmune Disorders of Connective Tissue: Merck Manual Home Health Handbook" />  ||  ||IFN-gamma, IL-1, TNF-alpha ||
 |- 
 |  [[Primary biliary cirrhosis]] || Accepted<ref name="titlePrimary Biliary Cirrhosis: Fatty Liver, Cirrhosis, and Related Disorders: Merck Manual Home Health Handbook">{{cite web |url=http://www.merckmanuals.com/home/liver_and_gallbladder_disorders/fatty_liver_cirrhosis_and_related_disorders/primary_biliary_cirrhosis.html |title=Primary Biliary Cirrhosis: Fatty Liver, Cirrhosis, and Related Disorders: Merck Manual Home Health Handbook |accessdate=2008-04-05 |work=}}</ref>   ||  || [[Anti-p62 antibodies|Anti-p62]], [[Anti-sp100 antibodies|Anti-sp100]], [[Anti-Mitochontrial(M@) antibodys|Anti-Mitochondrial(M2)]][[Anti-Ro]] aka SSA.<ref name="Franceschini2005" /> Also, they are often present in [[Sjögren's syndrome]].<ref name="Franceschini2005a" /><ref name="Goeb2007" /> ||
 |-
 |  [[Primary sclerosing cholangitis]] || || ||HLA-DR52a ||overlap with [[primary biliary cirrhosis]]?
 |-
  |  [[Progressive inflammatory neuropathy]] || Suspected || || ||
 |- 
 |  [[Psoriasis]]  || Accepted<ref>National Psoriasis Foundation, http://www.psoriasis.org/home/learn01.php</ref>   || IV?  
|| || CD-8 T-cells, [[HLA-C]]w6, [[IL-12b]], [[IL-23b]], TNFalpha, NF-κB
 |- 
 |  [[Psoriatic arthritis]]  || Accepted<ref>National Psoriasis Foundation, http://www.psoriasis.org/home/learn02.php</ref>   || IV? || || [[HLA=B27]] 
 |-
 |  [[Pyoderma gangrenosum]] || || || || Can occur in conjunction with other immune-related disorders
 |-
 |  [[Pure red cell aplasia]] || || || ||
 |-
 |  [[Rasmussen's encephalitis]] || || || anti-NR2A antibodies ||
 |-
 |  [[Raynaud phenomenon]] || Suspected|| || || Can occur in conjunction with other immune-related disorders
 |- 
 |  [[Relapsing polychondritis]] || Accepted<ref name=ADCTmmhe>{{cite web |url=http://www.merckmanuals.com/home/bone_joint_and_muscle_disorders/autoimmune_disorders_of_connective_tissue/relapsing_polychondritis.html |title=Relapsing Polychondritis: Autoimmune Disorders of Connective Tissue: Merck Manual Home Health Handbook |work= |accessdate=}}</ref>   ||    ||  || 
 |- 
 |  [[Reiter's syndrome]] || || || ||
 |-
 |  [[Restless leg syndrome]] || Suspected || || ||May occur in Sjögren's syndrome, celiac disease, and rheumatoid arthritis or in derangements of iron metabolism
 |-
 |  [[Retroperitoneal fibrosis]] || || || ||
 |-
 |  [[Rheumatoid arthritis]] || Accepted<ref name="Mesh"/>   || III || [[Rheumatoid factor]] (anti-IgGFc), [[Anti-MCV]], [[anti-citrullinated protein antibodies|ACPAs]]([[Vimentin]] || [[HLA-DR4]], [[PTPN22]], depleted B cells, TNF alpha, [[Interleukin 17|IL-17]], (also maybe IL-1, 6, and 15)
 |- 
 |  [[Rheumatic fever]] || Accepted<ref name=Girschick2008>{{cite journal |author=Girschick HJ, Guilherme L, Inman RD, Latsch K, Rihl M, Sherer Y, Shoenfeld Y, Zeidler H, Arienti S, Doria A |title=Bacterial triggers and autoimmune rheumatic diseases |journal=Clinical and Experimental Rheumatology |volume=26 |issue=1 Suppl 48 |pages=S12–7 |year=2008 |pmid=18570749 |doi= |url=}}</ref> ||II || streptococcal [[M protein (Streptococcus)|M protein]] cross reacts with human [[myosin]],<ref>{{cite journal |author=Faé KC, da Silva DD, Oshiro SE, ''et al.'' |title=Mimicry in recognition of cardiac myosin peptides by heart-intralesional T cell clones from rheumatic heart disease |journal=J. Immunol. |volume=176 |issue=9 |pages=5662–70 |year=2006 |month=May |pmid=16622036 |doi= |url=http://www.jimmunol.org/cgi/pmidlookup?view=long&pmid=16622036}}</ref> ||
 |-
 |  [[Sarcoidosis]]  || Suspected ||IV<ref name="urleMedicine - Hypersensitivity Reactions, Delayed : Article by Walter Duane Hinshaw">{{cite web |url=http://www.emedicine.com/MED/topic1100.htm |title=eMedicine - Hypersensitivity Reactions, Delayed : Article by Walter Duane Hinshaw |work= |accessdate=2008-09-18| archiveurl= http://web.archive.org/web/20080915175714/http://www.emedicine.com/MED/topic1100.htm| archivedate= 15 September 2008 <!--DASHBot-->| deadurl= no}}</ref><ref name="pmid11948059">{{cite journal |author=Morell F, Levy G, Orriols R, Ferrer J, De Gracia J, Sampol G |title=Delayed cutaneous hypersensitivity tests and lymphopenia as activity markers in sarcoidosis |journal=Chest |volume=121 |issue=4 |pages=1239–44 |year=2002 |month=April |pmid=11948059 |doi= 10.1378/chest.121.4.1239|url=http://www.chestjournal.org/cgi/pmidlookup?view=long&pmid=11948059}}</ref> || ||[[BTNL2]]; [[HLA-B7]]-[[HLA-DR15|DR15]]; [[HLA DR3-DQ2]].<ref name="pmid14656748">{{cite journal |author=Grunewald J, Eklund A, Olerup O |title=Human leukocyte antigen class I alleles and the disease course in sarcoidosis patients |journal=Am. J. Respir. Crit. Care Med. |volume=169 |issue=6 |pages=696–702 |year=2004 |month=March |pmid=14656748 |doi=10.1164/rccm.200303-459OC }}</ref>

 |-
 |  [[Schizophrenia]]   || Suspected<ref>{{cite journal |author=Eaton WW, Byrne M, Ewald H, ''et al'' |title=Association of schizophrenia and autoimmune diseases: linkage of Danish national registers |journal=The American Journal of Psychiatry |volume=163 |issue=3 |pages=521–8 |year=2006 |pmid=16513876 |doi=10.1176/appi.ajp.163.3.521}}</ref><ref>{{cite journal |author=Jones AL, Mowry BJ, Pender MP, Greer JM |title=Immune dysregulation and self-reactivity in schizophrenia: do some cases of schizophrenia have an autoimmune basis? |journal=Immunol. Cell Biol. |volume=83 |issue=1 |pages=9–17 |year=2005 |pmid=15661036 |doi=10.1111/j.1440-1711.2005.01305.x}}</ref><ref>{{cite journal |author=Strous RD, Shoenfeld Y |title=Schizophrenia, autoimmunity and immune system dysregulation: a comprehensive model updated and revisited |journal=J. Autoimmun. |volume=27 |issue=2 |pages=71–80 |year=2006 |pmid=16997531 |doi=10.1016/j.jaut.2006.07.006}}</ref>  ||  ||
 |- 
 |  [[Schmidt syndrome]] another form of APS || || ||anti-21 hydroxylase, anti-17 hydroxylase<ref name="pmid10664529">{{cite journal |author=de Carmo Silva R, Kater CE, Dib SA, ''et al'' |title=Autoantibodies against recombinant human steroidogenic enzymes 21-hydroxylase, side-chain cleavage and 17alpha-hydroxylase in Addison's disease and autoimmune polyendocrine syndrome type III |journal=Eur. J. Endocrinol. |volume=142 |issue=2 |pages=187–94 |year=2000 |month=February |pmid=10664529 |doi= 10.1530/eje.0.1420187|url=http://eje-online.org/cgi/pmidlookup?view=long&pmid=10664529 |accessdate=2008-07-25}}</ref>  ||DQ2, DQ8 and DRB1*0404
 |-
 |  [[Schnitzler syndrome]] || || || ||IgM?
 |-
 |  [[Scleritis]] || || || ||
 |-
 |  [[Scleroderma]]  || Suspected<ref name="pmid15561734"/>  ||IV? || [[Scl-70]] [[Anti-topoisomerase antibodies|Anti-topoisomerase]]|| dysregulated apoptosis?
 |-
 |  [[Serum Sickness]] || ||III || ||
 |- 
 |  [[Sjögren's syndrome]]  || Accepted<ref name = "Mesh"/>   ||  ||[[Anti-ro]].<ref name="Franceschini2005" /> Also, they are often present in [[Sjögren's syndrome]].<ref name="Franceschini2005a" /><ref name="Goeb2007" /> ||
 |-
 |  [[Spondyloarthropathy]] || || || || [[HLA-B27]] 
 |-
 |  [[Juvenile idiopathic arthritis|Still's disease]] see [[Juvenile Rheumatoid Arthritis]] || || || [[Anti-nuclear antibody|ANA]] ||[[macrophage migration inhibitory factor]]<ref name="pmid12746913">{{cite journal |author=De Benedetti F, Meazza C, Vivarelli M, ''et al.'' |title=Functional and prognostic relevance of the -173 polymorphism of the macrophage migration inhibitory factor gene in systemic-onset juvenile idiopathic arthritis |journal=Arthritis Rheum. |volume=48 |issue=5 |pages=1398–407 |year=2003 |month=May |pmid=12746913 |doi=10.1002/art.10882}}</ref>
 |- 
 |  [[Stiff person syndrome]]  || Suspected||  ||[[L-glutamic acid decarboxylase|glutamic acid decarboxylase]] (GAD),<ref name="Murinson">{{cite journal | author=Murinson BB | title=Stiff-person syndrome | journal=Neurologist | year=2004 | pages=131–7 | volume=10 | issue=3  | pmid=15140273 | doi=10.1097/01.nrl.0000126587.37087.1a}}</ref> ||[[GLRA1]] ([[glycine receptor]])
 |-
 |  [[Subacute bacterial endocarditis]] (SBE) || ||III <ref name="pmid9402102">{{citation |journal=J. Am. Soc. Nephrol. |volume=8 |issue=12 |pages=1971–6 |year=1997 |month=December |pmid=9402102 |doi= |url=http://jasn.asnjournals.org/cgi/pmidlookup?view=long&pmid=9402102}}</ref> ||essential mixed cryoglobulinemia ||
 |-
 |  [[Susac's syndrome]] || || || ||
 |-
 |  [[Sweet's syndrome]] || || || ||[[granulocyte colony-stimulating factor|GCSF]]
 |-
 |  [[Sydenham chorea]] see [[PANDAS]]  || || || ||
 |-
 |  [[Sympathetic ophthalmia]] || || || ocular antigens following trauma ||
 |-
 |  [[Systemic lupus erythematosis]] see Lupus erythematosis|| ||III || ||
 |-
 |  [[Takayasu's arteritis]] || || ||
 |- 
 |  [[Temporal arteritis]] (also known as "giant cell arteritis")  || Accepted<ref name="Mesh" />   ||  IV ||
 |-
 |  [[Thrombocytopenia]] || ||II ||[[glycoprotein]]s [[IIb-IIIa]] or [[Ib-IX]] in [[Idiopathic thrombocytopenic purpura|ITP]] anti-ADAMTS13 in [[Thrombotic thrombocytopenic purpura|TTP]].<ref name=Moake2004>{{cite journal |author=Moake JL |title=von Willebrand factor, ADAMTS-13, and thrombotic thrombocytopenic purpura |journal=Semin. Hematol. |volume=41 |issue=1 |pages=4–14 |year=2004 |pmid=14727254|doi=10.1053/j.seminhematol.2003.10.003}}</ref> and [[Hemolytic-uremic syndrome|HUS]] anti-[[cardiolipin]] ([[anti-cardiolipin antibodies]]) and [[apolipoprotein H|β<sub>2</sub> glycoprotein I]] in [[Antiphospholipid syndrome]] anti-[[HPA-1a]],  anti-[[HPA-5b]], and others<ref>{{cite journal | author = Mueller-Eckhardt C, Kiefel V, Grubert A, Kroll H, Weisheit M, Schmidt S ''et al.'' | year = 1989 | title = 348 cases of fetal alloimmune thrombocytopenia | url = | journal = Lancet | volume = 1 | issue = 8634| pages = 363–6 | doi = 10.1016/S0140-6736(89)91733-9 | pmid = 2563515 }}</ref> in [[Neonatal alloimmune thrombocytopenia|NAIT]] || multiple mechanisms

 |-
 |  [[Tolosa-Hunt syndrome]] || || || ||
 |-
 |  [[Transverse myelitis]] ||Accepted || ||  || Transverse Myelitis is a rare neurological disorder that is part of a spectrum of neuroimmunologic diseases of the central nervous system. http://www.myelitis.org/
 |-
 |  [[Ulcerative colitis]] (one of two types of idiopathic inflammatory bowel disease "IBD")  || Accepted<ref name="Mesh" />   ||  IV ||
 |-
 |  [[Undifferentiated connective tissue disease]] different from Mixed connective tissue disease || Accepted   || ||  [[anti-nuclear antibody]]  || [[HLA-DR4]]
 |-
 |  [[Undifferentiated spondyloarthropathy]] || || ||
 |- 
 |  [[Urticarial vasculitis]] || ||II? ||anti C1q antibodies<ref name="pmid2528353">{{cite journal |author=Wisnieski JJ, Naff GB |title=Serum IgG antibodies to C1q in hypocomplementemic urticarial vasculitis syndrome |journal=Arthritis Rheum |volume=32 |issue=9 |pages=1119–27 |year=1989 |month=September |pmid=2528353 |doi=10.1002/anr.1780320910 }}</ref> || clinically may resemble type I hypersensitivity!
 |-
 |  [[Vasculitis]] || Accepted<ref name="urlAutoimmune Disorders: Immune Disorders: Merck Manual Home Edition" />  || III || sometimes ANCA ||
 |- 
 |  [[Vitiligo]]  || Suspected<ref>{{cite web |url=http://www.niams.nih.gov/hi/topics/vitiligo/vitiligo.htm |title=Questions and Answers about Vitiligo |accessdate=2007-08-06 |work=}}</ref><ref>{{cite web |url=http://dermatology.jwatch.org/cgi/content/full/2007/330/1 |title=A New Gene Linked to Vitiligo and Susceptibility to Autoimmune Disorders - Journal Watch Dermatology |accessdate=2007-08-06 |work=| archiveurl= http://web.archive.org/web/20070903191751/http://dermatology.jwatch.org/cgi/content/full/2007/330/1| archivedate= 3 September 2007 <!--DASHBot-->| deadurl= no}}</ref>  ||  || ||NALP-1 RERE, PTPN22, LPP, IL2RA, GZMB, UBASH3A and C1QTNF6
 |- 
 |  [[Wegener's granulomatosis]]  || Accepted<ref name="pmid18391678">{{cite journal |author=Sánchez-Cano D, Callejas-Rubio JL, Ortego-Centeno N |title=Effect of rituximab on refractory Wegener granulomatosis with predominant granulomatous disease |journal=J Clin Rheumatol |volume=14 |issue=2 |pages=92–3 |year=2008 |month=April |pmid=18391678 |doi=10.1097/RHU.0b013e31816b4487 |url=http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?an=00124743-200804000-00008 }}</ref>  ||  || [[Anti-neutrophil cytoplasmic antibody|Anti-neutrophil cytoplasmic(cANCA)]] ||
|}

==Development of therapies==
In both autoimmune and inflammatory diseases the condition arises through aberrant reactions of the human adaptive or innate immune systems. In autoimmunity, the patient’s immune system is activated against the body's own proteins. In inflammatory diseases, it is the overreaction of the immune system, and its subsequent downstream signaling (TNF, IFN, etc.), which causes problems. Mitigation of inflammation by activation of anti-inflammatory genes and the suppression of inflammatory genes in immune cells is a promising way of novel therapies.<ref>{{cite journal | author = Mukundan L, Odegaard JI, Morel CR, Heredia JE, Mwangi JW, Ricardo-Gonzalez RR, Goh YP, Eagle AR, Dunn SE ''et al.'' | year = 2009 | month = Nov | title = PPAR-delta senses and orchestrates clearance of apoptotic cells to promote tolerance | url = | journal = Nat Med | volume = 15 | issue = 11| pages = 1266–72 }}</ref><ref>{{cite journal | author = Roszer T, Menéndez-Gutiérrez MP, Lefterova MI, Alameda D, Núñez V, Lazar MA, Fischer T, Ricote M | year = 2011 | month = Jan | title = Autoimmune kidney disease and impaired engulfment of apoptotic cells in mice with macrophage peroxisome proliferator-activated receptor gamma or retinoid X receptor alpha deficiency | url = | journal = J Immunol | volume = 186 | issue = 1| pages = 621–31 }}</ref><ref>Singh RP, Waldron RT, Hahn BH. (2011) Genes, tolerance and systemic autoimmunity. Autoimmun Rev. 2011 Nov 30.</ref>

A substantial minority of the population suffers from these diseases, which are often chronic, debilitating, and life-threatening. There are more than eighty illnesses caused by autoimmunity.<ref>[http://www.nlm.nih.gov/medlineplus/ency/article/000816.htm National Institutes of Health]</ref> It has been estimated that autoimmune diseases are among the ten leading causes of death among women in all age groups up to 65 years.<ref>Noel R. Rose and Ian R. MacKay, "The Autoimmune Diseases" fourth edition</ref>

==See also==
*[[Autoimmunity]]
*[[Immune-mediated disease]]

== Further reading ==
*Vinay Kumar, Abul K. Abbas, Nelson Fausto, Jon Aster, ''Robbins and Cotran Pathologic Basis of Disease'', Elsevier, 8th edition, 2010, 1464 pp., ISBN 978-1-4160-3121-5
*''Handbook of Systemic Autoimmune Diseases'', edited by Ronald Asherson, Elsevier, in 10 Volumes:<ref>http://www.elsevier.com/wps/find/bookdescription.cws_home/BS_HSAD/description#description</ref>  
** Ronald Asherson, Andrea Doria, Paolo Pauletto, ''The Heart in Systemic Autoimmune Diseases'', Volume 1, 2004, ISBN 978-0-444-51398-4, ISBN 0-444-51398-1
** Ronald Asherson, Andrea Doria, Paolo Pauletto, ''Pulmonary Involvement in Systemic Autoimmune Diseases'', Volume 2, 2005, ISBN 978-0-444-51652-7, ISBN 0-444-51652-2
** Ronald Asherson, Doruk Erkan, Steven Levine, ''The Neurologic Involvement in Systemic Autoimmune Diseases'', Volume 3, 2005, ISBN 978-0-444-51651-0, ISBN 0-444-51651-4
** Michael Lockshin, Ware Branch (eds), ''Reproductive and Hormonal Aspects of Systemic Autoimmune Diseases'', Volume 4, 2006, ISBN 978-0-444-51801-9, ISBN 0-444-51801-0
** Piercarlo Sarzi-Puttini, Ronald Asherson, Andrea Doria, Annegret Kuhn, Giampietro Girolomoni (eds), ''The Skin in Systemic Autoimmune Diseases'', Volume Volume 5, 2006, ISBN 978-0-444-52158-3, ISBN 0-444-52158-5
** Rolando Cimaz, Ronald Asherson, Thomas Lehman (eds), ''Pediatrics in Systemic Autoimmune Diseases'', Volume 6, 2008, ISBN 978-0-444-52971-8, ISBN 0-444-52971-3
** Justin Mason, Ronald Asherson, Charles Pusey (eds), ''The Kidney in Systemic Autoimmune Diseases'', Volume 7, 2008, ISBN 978-0-444-52972-5, ISBN 0-444-52972-1
** Ronald Asherson, Manel Ramos-Casals, Joan Rodes, Josep Font, ''Digestive Involvement in Systemic Autoimmune Diseases'', Volume 8, 2008, ISBN 978-0-444-53168-1, ISBN 0-444-53168-8
** Ronald Asherson, Sara Walker, Luis Jara, ''Endocrine Manifestations of Systemic Autoimmune Diseases'', Volume 9, 2008, ISBN 978-0-444-53172-8, ISBN 0-444-53172-6
** R. Cervera, Ronald Asherson, Munther Khamashta, Joan Carles Reverter (eds), ''Antiphospholipid Syndrome in Systemic Autoimmune Diseases'', Volume 10, 2009, ISBN 978-0-444-53169-8, ISBN 0-444-53169-6

==References==
{{Reflist|2}}

==External links==
* {{DMOZ|/Health/Conditions_and_Diseases/Immune_Disorders/Auto-Immune/|Auto-immune disorders}}

{{Autoimmune diseases}}

{{DEFAULTSORT:Autoimmune Disease}}
[[Category:Autoimmune diseases| ]]